Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option (Q35678065)

9 August 2017

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

5

J H Beijnen

1 reference

9 August 2017

D Meulendijks

1

1 reference

9 August 2017

L Dewit

2

1 reference

9 August 2017

N B Tomasoa

3

1 reference

9 August 2017

H van Tinteren

4

1 reference

9 August 2017

J H M Schellens

6

1 reference

9 August 2017

A Cats

7

1 reference

9 August 2017

language of work or name

English

0 references

publication date

28 August 2014

1 reference

British Journal of Cancer

9 August 2017

1 reference

9 August 2017

111

1 reference

9 August 2017

9

1 reference

9 August 2017

1726-1733

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2014.467

9 August 2017

0 references

cites work

Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Cellular pharmacology of fluorinated pyrimidines in vivo in man.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4453727

Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.

27 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

“Mind the Gap”—The Impact of Variations in the Duration of the Treatment Gap and Overall Treatment Time in the First UK Anal Cancer Trial (ACT I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.467

X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts

21 January 2018

1 reference

12 December 2020

A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity

1 reference

12 December 2020

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research

1 reference

12 December 2020

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

12 December 2020

Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal

1 reference

12 December 2020

Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy

1 reference

12 December 2020

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2014.467

1 reference

9 August 2017

1 reference

9 August 2017

1 reference